Heavily indebted poor countries (HIPC) vs Malaysia: Antiretroviral therapy coverage for PMTCT
Heavily indebted poor countries (HIPC)
84.7%
in 2024
Malaysia
99.0%
in 2024
Heavily indebted poor countries (HIPC) rank
7th
Malaysia rank
5th
Antiretroviral therapy coverage for PMTCT over time
- Heavily indebted poor countries (HIPC)
- Malaysia
How they compare
Malaysia currently reports 99.0% against 84.7% in Heavily indebted poor countries (HIPC), a difference of 14.3%.
That makes Malaysia's figure about 1.2 times Heavily indebted poor countries (HIPC)'s.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Malaysia ahead.
Heavily indebted poor countries (HIPC) ranks 7th and Malaysia ranks 5th of 15 groups.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Heavily indebted poor countries (HIPC) | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.2% | 86.7% | 69.5% | Malaysia |
| 2010s | 71.9% | 77.3% | 5.4% | Malaysia |
| 2020s | 84.1% | 98.0% | 13.9% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Heavily indebted poor countries (HIPC) or Malaysia?
- Malaysia, at 99.0% against 84.7% in Heavily indebted poor countries (HIPC) as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Heavily indebted poor countries (HIPC) and Malaysia?
- 14.3%, with Malaysia ahead.
- How many years of comparable data are there for Heavily indebted poor countries (HIPC) and Malaysia?
- 25 years are reported by both, from 2000 to 2024.
- How do Heavily indebted poor countries (HIPC) and Malaysia rank globally for antiretroviral therapy coverage for pmtct?
- Heavily indebted poor countries (HIPC) ranks 7th and Malaysia ranks 5th of 15 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).